Distinctive patterns of inflammation across the heart failure syndrome
- 26 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Heart Failure Reviews
- Vol. 26 (6), 1333-1344
- https://doi.org/10.1007/s10741-020-09949-5
Abstract
Inflammation has long been known to play a role in heart failure (HF). Earlier studies demonstrated that inflammation contributes to the pathogenesis of HF with reduced ejection fraction (HFrEF), and the knowledge about molecules and cell types specifically involved in inflammatory events has been constantly increased ever since. However, conflicting results of several trials with anti-inflammatory treatments led to the conclusions that inflammation does participate in the progression of HFrEF, but more likely it is not the primary event. Conversely, it has been suggested that inflammation drives the development of HF with preserved ejection fraction (HFpEF). Recently the pharmacological blockade of interleukin-1 has been shown to prevent HF hospitalization and mortality in patients with prior myocardial infarction, lending renewed support to the hypothesis that inflammation is a promising therapeutic target in HF. Inflammation has also been proposed to underlie both HF and commonly associated conditions, such as chronic kidney disease or cancer. Within this last paradigm, an emergent role has been ascribed to clonal hematopoiesis of indeterminate potential. Here, we summarize the recent evidence about the role of inflammation in HF, highlighting the similarities and differences in HFrEF vs. HFpEF, and discuss the diagnostic and therapeutic opportunities raised by antinflammatory-based approaches.Keywords
Funding Information
- University of Genova (Fondo di Ricerca d'Ateneo 2019)
This publication has 93 references indexed in Scilit:
- Common threads in cardiac fibrosis, infarct scar formation, and wound healingFibrogenesis & Tissue Repair, 2012
- MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarctionJournal of Molecular and Cellular Cardiology, 2012
- Sildenafil and B-Type Natriuretic Peptide Acutely Phosphorylate Titin and Improve Diastolic Distensibility In VivoCirculation, 2011
- Diabetes Mellitus Worsens Diastolic Left Ventricular Dysfunction in Aortic Stenosis Through Altered Myocardial Structure and Cardiomyocyte StiffnessCirculation, 2011
- High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart FailureCirculation: Heart Failure, 2011
- Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection FractionJournal of the American College of Cardiology, 2010
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLoS Medicine, 2006
- Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human MyocardiumCirculation, 2006
- Alterations in the creatine kinase system in the myocardium of cardiomyopathic hamstersBiochemical and Biophysical Research Communications, 1989